---
figid: PMC9180978__ijms-23-06232-g003
figtitle: Soluble Epoxide Hydrolase and Diabetes Complications
organisms:
- Mus musculus
- Rattus norvegicus
- Candida dubliniensis
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9180978
filename: ijms-23-06232-g003.jpg
figlink: /pmc/articles/PMC9180978/figure/ijms-23-06232-f003/
number: F3
caption: 'Some potential mechanisms related to effects of the cytochrome P450-soluble
  epoxide hydrolase (CYP450-sEH) pathway. The vascular endothelial cells release EpETrEs
  onto the vascular smooth muscle cells, leading to vasodilation. Cell stressors including
  shear stress, inflammation, metabolic stress, and angiotensin, can interrupt this
  process; they can exacerbate ER stress in endothelial cells, leading to endothelial
  dysfunction and vessel inflammation [,]. Laminar flow has an anti-inflammatory effect
  involving PPARg signaling, which is disrupted by shear stress []. Shear stress and
  angiotensin II increase sEH expression [,]. Inhibition of sEH attenuates ER stress
  by an unknown mechanism that may involve elevated epoxides and/or decreased diols,
  which attenuates production of inflammatory cytokines and chemokines, and membrane
  permeability [,,,,]. By reducing NFkB-dependent TNF signaling [], epoxides may reduce
  the expression of NOX4, which would generate reactive oxygen species (ROS) in the
  ER, and reduce the expression of NLRP3 inflammasome components, which would exacerbate
  inflammation []. The mitochondria can be activated by Ca2+ from the ER, generating
  ROS that activate the inflammasome. Mitochondrial dysfunction can lead to programmed
  cell death, which can be exacerbated by Bax expression due to ER stress []. Therefore,
  the epoxides and/or diols, and sEH inhibitors, may affect cross-talk between the
  ER, mitochondria and NLRP3 inflammasome, attenuating inflammation, apoptosis, and
  the effects of oxidative stress [,,]. Abbreviations: EpETrE, epoxyeicosatrienoic
  acid; DiHETrE, dihydroxyepoxyeicosatrienoic acid; ER, endoplasmic reticulum; SR,
  sarcoplasmic reticulum; PPARg, peroxisome proliferator-activated receptor gamma;
  sEH, soluble epoxide hydrolase; NFkB, nuclear factor kappa B; TNF, tumor necrosis
  factor; TNFR, tumor necrosis factor receptor; NOX4, NADPH oxidase 4; NLRP3, NOD-,
  LRR- and pyrin domain-containing protein 3; Bax, Bcl-2-associated X protein; LCC,
  L-type calcium channel; TRPV4, transient receptor potential vanilloid 4; AA, arachidonic
  acid; DHA, docosahexaenoic acid; RyR, ryanodine receptors; IRE1, inositol-requiring
  protein-1α; PERK, protein kinase RNA (PKR)-like ER kinase; ATF6, activating transcription
  factor 6; ATF4, activating transcription factor 4; XBP1, X-Box Binding Protein 1;
  eIF2α, eukaryotic initiation factor 2α; EpDPE, epoxydocosapentaenoic acid; DiHDPE,
  dihydroxydocosapentaenoic acid; Erk1/2, extracellular signal-regulated protein kinase
  1/2; CHOP, CCAAT-enhancer-binding protein homologous protein; DDIT3, DNA damage
  inducible transcript 3; COX-2, cyclooxygenase-2; RIPK1, receptor-interacting serine/threonine-protein
  kinase 1; IKK, IKB kinase; IL-1, interleukin-1; IL-6, interleukin-6; MCP-1, monocyte
  chemoattractant protein-1; VCAM-1, vascular cell adhesion protein 1; STAT3, signal
  transducer and activator of transcription 3; AMPK/HO-1, AMP-activated protein kinase/
  hemoxygenase-1; VE-cadherin, vascular endothelial -cadherin; MAPK, mitogen-activated
  protein kinase; ZO-1, zonula occludens-1; ASC, apoptosis-associated speck-like protein
  containing a CARD; mt, mitochondrial; SOD, superoxide dismutase; CREB, cAMP Response
  Element-Binding Protein; BDNF, brain derived neurotrophic factor; VDCC, voltage-dependent
  calcium channels; BKCa, Ca2+-activated K+ channels; KATP, ATP-sensitive potassium
  channel. Created with BioRender.com.'
papertitle: Soluble Epoxide Hydrolase and Diabetes Complications.
reftext: Natasha Z. Anita, et al. Int J Mol Sci. 2022 Jun;23(11):6232.
year: '2022'
doi: 10.3390/ijms23116232
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: sEH | type 2 diabetes mellitus | microvascular
automl_pathway: 0.8816403
figid_alias: PMC9180978__F3
figtype: Figure
redirect_from: /figures/PMC9180978__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9180978__ijms-23-06232-g003.html
  '@type': Dataset
  description: 'Some potential mechanisms related to effects of the cytochrome P450-soluble
    epoxide hydrolase (CYP450-sEH) pathway. The vascular endothelial cells release
    EpETrEs onto the vascular smooth muscle cells, leading to vasodilation. Cell stressors
    including shear stress, inflammation, metabolic stress, and angiotensin, can interrupt
    this process; they can exacerbate ER stress in endothelial cells, leading to endothelial
    dysfunction and vessel inflammation [,]. Laminar flow has an anti-inflammatory
    effect involving PPARg signaling, which is disrupted by shear stress []. Shear
    stress and angiotensin II increase sEH expression [,]. Inhibition of sEH attenuates
    ER stress by an unknown mechanism that may involve elevated epoxides and/or decreased
    diols, which attenuates production of inflammatory cytokines and chemokines, and
    membrane permeability [,,,,]. By reducing NFkB-dependent TNF signaling [], epoxides
    may reduce the expression of NOX4, which would generate reactive oxygen species
    (ROS) in the ER, and reduce the expression of NLRP3 inflammasome components, which
    would exacerbate inflammation []. The mitochondria can be activated by Ca2+ from
    the ER, generating ROS that activate the inflammasome. Mitochondrial dysfunction
    can lead to programmed cell death, which can be exacerbated by Bax expression
    due to ER stress []. Therefore, the epoxides and/or diols, and sEH inhibitors,
    may affect cross-talk between the ER, mitochondria and NLRP3 inflammasome, attenuating
    inflammation, apoptosis, and the effects of oxidative stress [,,]. Abbreviations:
    EpETrE, epoxyeicosatrienoic acid; DiHETrE, dihydroxyepoxyeicosatrienoic acid;
    ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; PPARg, peroxisome proliferator-activated
    receptor gamma; sEH, soluble epoxide hydrolase; NFkB, nuclear factor kappa B;
    TNF, tumor necrosis factor; TNFR, tumor necrosis factor receptor; NOX4, NADPH
    oxidase 4; NLRP3, NOD-, LRR- and pyrin domain-containing protein 3; Bax, Bcl-2-associated
    X protein; LCC, L-type calcium channel; TRPV4, transient receptor potential vanilloid
    4; AA, arachidonic acid; DHA, docosahexaenoic acid; RyR, ryanodine receptors;
    IRE1, inositol-requiring protein-1α; PERK, protein kinase RNA (PKR)-like ER kinase;
    ATF6, activating transcription factor 6; ATF4, activating transcription factor
    4; XBP1, X-Box Binding Protein 1; eIF2α, eukaryotic initiation factor 2α; EpDPE,
    epoxydocosapentaenoic acid; DiHDPE, dihydroxydocosapentaenoic acid; Erk1/2, extracellular
    signal-regulated protein kinase 1/2; CHOP, CCAAT-enhancer-binding protein homologous
    protein; DDIT3, DNA damage inducible transcript 3; COX-2, cyclooxygenase-2; RIPK1,
    receptor-interacting serine/threonine-protein kinase 1; IKK, IKB kinase; IL-1,
    interleukin-1; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1;
    VCAM-1, vascular cell adhesion protein 1; STAT3, signal transducer and activator
    of transcription 3; AMPK/HO-1, AMP-activated protein kinase/ hemoxygenase-1; VE-cadherin,
    vascular endothelial -cadherin; MAPK, mitogen-activated protein kinase; ZO-1,
    zonula occludens-1; ASC, apoptosis-associated speck-like protein containing a
    CARD; mt, mitochondrial; SOD, superoxide dismutase; CREB, cAMP Response Element-Binding
    Protein; BDNF, brain derived neurotrophic factor; VDCC, voltage-dependent calcium
    channels; BKCa, Ca2+-activated K+ channels; KATP, ATP-sensitive potassium channel.
    Created with BioRender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trpv4
  - Cyp3a23-3a1
  - Atf4
  - Ddit3
  - Pmaip1
  - Bax
  - Mapk3
  - Mapk1
  - Ptgs2
  - Neb
  - Nfkb1
  - Rela
  - Nox4
  - Tnf
  - Nlrp3
  - Ccl2
  - Vcam1
  - Il6
  - Hmox1
  - Prkaa2
  - Akt1
  - Pik3cg
  - Cdh5
  - Creb1
  - Bak1
  - Il18
  - TRPV4
  - PPIG
  - CYP17A1
  - CYP19A1
  - CYP20A1
  - CYP21A2
  - CYP24A1
  - CYP39A1
  - TBXAS1
  - CYP46A1
  - CYP51A1
  - CYP1A1
  - CYP1A2
  - CYP1B1
  - CYP11A1
  - CYP11B1
  - CYP11B2
  - CYP2A13
  - CYP2A6
  - CYP2A7
  - CYP2B6
  - CYP2C18
  - CYP2C19
  - CYP2C8
  - CYP2C9
  - CYP2D6
  - CYP2D7
  - CYP2E1
  - CYP2F1
  - CYP2J2
  - CYP2R1
  - CYP2S1
  - CYP2U1
  - CYP2W1
  - CYP26A1
  - CYP26B1
  - CYP26C1
  - CYP27A1
  - CYP27B1
  - CYP27C1
  - CYP3A4
  - CYP3A43
  - CYP3A5
  - CYP3A7
  - CYP4A11
  - CYP4A22
  - CYP4B1
  - CYP4F11
  - CYP4F12
  - CYP4F2
  - CYP4F22
  - CYP4F3
  - CYP4F8
  - CYP4V2
  - CYP4X1
  - CYP4Z1
  - CYP7A1
  - CYP7B1
  - CYP8B1
  - PTGIS
  - EIF2AK3
  - ATF4
  - DDIT3
  - PMAIP1
  - BAX
  - SFRP4
  - MAPK3
  - MAPK1
  - PTGS2
  - CBLIF
  - NEB
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TNFRSF1A
  - NOX4
  - TNF
  - NLRP3
  - CCL2
  - VCAM1
  - IL6
  - HMOX1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDH5
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - BAK1
  - IL18
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - Ptprc
  - H2-Aa
  - Ppig
  - Eif2ak3
  - Lamp1
  - Nkx3-1
  - Cblif
  - Tnfrsf1a
  - Mcpt1
  - Pik3r1
  - adamts9
  - trpv4
  - dharma
  - atf4a
  - baxa
  - ddit3
  - mapk3
  - COX2
  - neb
  - nox4
  - tnfrsfa
  - tnfb
  - nlrp3
  - vcam1b
  - il6
  - cdh5
  - DHA
  - Pyl
---
